Aclaris Therapeutics develops prescription drug candidates, testing them in clinical trials and planning to sell approved products through partners. It last closed at $3.44 on Nov 20, down 1.71% on the day. The next earnings report for ACRS is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, ACRS reported EPS of -$0.12 on revenue of $1.5M, with revenue down 55.1% from a year ago. Over its last 8 reports the stock moved an average of 3.1% the session after earnings. Over the last 12 months ACRS insiders bought $0 of stock on the open market and sold $1.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is ACRS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ACRS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ACRSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ACRS · as of the Nov 20 close · updated each morning
Downtrend
The stock is 11% below its 20 day and 22% below its 50 day average. It is 32% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the Pivot S1 at $3.38, and the nearest resistance the Pivot at $3.46.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 8.7%/day
Key levels
$6.6052 week high+91.9%
$5.00100 day average+45.3%
$4.54200 day average+32.0%
$4.2150 day average+22.4%
$4.08Swing high (Nov 2)+18.6%
$3.8220 day average+11.0%
$3.52Pivot R1+2.3%
$3.46Pivot+0.6%
$3.44Last close
$3.38Pivot S1−1.7%
$3.25Swing low (Oct 16)−5.5%
$2.3452 week low−32.0%
Indicators
RSI (14)
38.98
Weak, oversold below 30
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
19.6
Near the bottom of its range
Oversold
ADX (14)
30.3
Trending down
Williams %R
-83.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-110.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.8%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 8.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 20.2%/day
Key levels
$6.6052 week high+91.9%
$5.00100 day average+45.3%
$4.54200 day average+32.0%
$4.2150 day average+22.4%
$4.08Swing high (Nov 2)+18.6%
$3.8220 day average+11.0%
$3.52Pivot R1+2.3%
$3.46Pivot+0.6%
$3.44Last close
$3.38Pivot S1−1.7%
$3.25Swing low (Oct 16)−5.5%
$2.3452 week low−32.0%
Indicators
RSI (14)
38.56
Weak, oversold below 30
Neutral
MACD
-0.23
Below its signal line
Bearish
Stochastic
16.7
Near the bottom of its range
Oversold
ADX (14)
30.1
Trending down
Williams %R
-92.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-111.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−35.3%
Change over 10 sessions
Bearish
ATR (14)
$0.70
Typical daily range, 20.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for ACRS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ACRS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ACRS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ACRSHow many large options trades hit ACRS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ACRS in the last 90 days.
From SEC Form 4 filings by ACRS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ACRS is in one of them and how their past ACRS trades turned out.
Aclaris Therapeutics is a pharmaceutical company based in Wayne, Pennsylvania. It develops prescription drug product candidates and tests them in clinical trials, relying on outside research organizations to run much of that work. The company plans to bring approved products to patients through outside partners, who would sell them to patients, insurers and government health programs. It also depends on outside suppliers to manufacture the drug supplies used in its trials.